cas 2092707-38-3|| where to buy 2-oxaspiro[3.5]nonan-7-ol

Название продукции:2-oxaspiro[3.5]nonan-7-ol

IUPAC Name:2-oxaspiro[3.5]nonan-7-ol

Упаковочная единица	Доступно для заказа	Цена ($)
CM855572-100mg	in stock	ǯĽ
CM855572-250mg	in stock	ǊƄư
CM855572-1g	in stock	ȎƞĽ
CM855572-5g	in stock	ǊźƄź

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2092707-38-3 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:2092707-38-3; Молекулярная формула:C8H14O2; Точка плавления:-; Smiles-код:OC1CCC2(COC2)CC1; Плотность:

: Номер в каталоге:CM855572; Молекулярная масса:142.2; Точка кипения:; Номер Mdl:; Хранение:

: Cyclohexanes; Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.